RENAU.UNSP.ARD 1/5 EO-20 - Asset Resilience Ratio

Latest as of March 2026: 0.32%

RENAU.UNSP.ARD 1/5 EO-20 (56S0) has an Asset Resilience Ratio of 0.32% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 56S0 financial flexibility index to measure the company's free cash flow as a share of total liabilities.

Liquid Assets

€26.20 Million
≈ $30.63 Million USD Cash + Short-term Investments

Total Assets

€8.19 Billion
≈ $9.57 Billion USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2022–2025)

This chart shows how RENAU.UNSP.ARD 1/5 EO-20's Asset Resilience Ratio has changed over time. See debt-free asset ratio of RENAU.UNSP.ARD 1/5 EO-20 to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down RENAU.UNSP.ARD 1/5 EO-20's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see RENAU.UNSP.ARD 1/5 EO-20 (56S0) total market value.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents €0.00 0%
Short-term Investments €26.20 Million 0.32%
Total Liquid Assets €26.20 Million 0.32%

Asset Resilience Insights

  • Limited Liquidity: RENAU.UNSP.ARD 1/5 EO-20 maintains only 0.32% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

RENAU.UNSP.ARD 1/5 EO-20 Industry Peers by Asset Resilience Ratio

Compare RENAU.UNSP.ARD 1/5 EO-20's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
QITIAN Technology Group Co Ltd
SHE:300061
Medical Instruments & Supplies 0.00%
Ansell Ltd
AU:ANN
Medical Instruments & Supplies 7.53%
Nanosonics Ltd
AU:NAN
Medical Instruments & Supplies 46.84%
SDI Ltd
AU:SDI
Medical Instruments & Supplies 3.36%
Austco Healthcare Ltd
AU:AHC
Medical Instruments & Supplies 15.90%
Trajan Group Holdings Ltd
AU:TRJ
Medical Instruments & Supplies 0.29%
Osteopore Ltd
AU:OSX
Medical Instruments & Supplies 22.60%
Nyxoah
BR:NYXH
Medical Instruments & Supplies 12.40%

Annual Asset Resilience Ratio for RENAU.UNSP.ARD 1/5 EO-20 (2022–2025)

The table below shows the annual Asset Resilience Ratio data for RENAU.UNSP.ARD 1/5 EO-20.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 0.10% €8.10 Million
≈ $9.47 Million
€7.98 Billion
≈ $9.33 Billion
-0.02pp
2024-12-31 0.12% €9.90 Million
≈ $11.57 Million
€8.26 Billion
≈ $9.65 Billion
0.00pp
2023-12-31 0.12% €9.50 Million
≈ $11.11 Million
€7.73 Billion
≈ $9.04 Billion
-0.39pp
2022-12-31 0.51% €25.90 Million
≈ $30.28 Million
€5.07 Billion
≈ $5.92 Billion
--
pp = percentage points

About RENAU.UNSP.ARD 1/5 EO-20

F:56S0 Germany Medical Instruments & Supplies
Market Cap
$18.08 Billion
€15.47 Billion EUR
Market Cap Rank
#1610 Global
#347 in Germany
Share Price
€15.90
Change (1 day)
+1.27%
52-Week Range
€14.60 - €21.80
All Time High
€35.31
About

Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; reagents; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transp… Read more